GlassScriptPhysician profile
Kara L Cooper
NPI 1588671747
$874.53
in general payments reported to CMS, 2019-2025
16 companies · $35.90 in 2025
The $35.90 reported for 2025 was less than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $11.03 · 2020: $77.79 · 2021: $216 · 2022: $210 · 2023: $203 · 2024: $122 · 2025: $35.90.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $360.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $360.32 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $224.45 | 2020-2023 | Ozempic, Rybelsus, Wegovy |
| Glaxosmithkline, LLC. | $127.08 | 2020-2023 | Trelegy Ellipta |
| Abbvie INC. | $108.62 | 2021-2025 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $69.48 | 2019-2023 | Xifaxan |
| Astrazeneca Pharmaceuticals LP | $58.74 | 2020-2021 | |
| Amgen INC. | $45.02 | 2022-2025 | Prolia, Evenity, Repatha |
| Bayer Healthcare Pharmaceuticals INC. | $44.90 | 2021-2022 | |
| Axonics, INC. | $37.83 | 2024 | Axonics |
| Lilly USA, LLC | $36.72 | 2021 | |
| Pfizer INC. | $31.81 | 2023-2024 | |
| Abbott Laboratories | $24.17 | 2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $15.07 | 2023 | Jardiance |
| Daiichi Sankyo INC. | $14.80 | 2021 | |
| Amarin Pharma, INC. | $14.29 | 2021 | |
| Merck Sharp & Dohme LLC | $12.01 | 2021 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Corium, LLC | $9.54 | 2023 | Adlarity |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kara Cooper listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.